Impel NeuroPharma Garners $12,000,000 Series B Financing
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=07f5baca-7f3c-4075-a2f5-2480a4303165 - Date
10/15/2015 - Company Name
Impel NeuroPharma - Mailing Address
915 East Pine Street Seattle, WA 98122 USA - Company Description
Impel NeuroPharma was founded with a mission to enable drugs to bypass the blood brain barrier. Co-founders Rodney Ho, Ph.D., John Hoekman, Ph.D., and Michael Hite began their work together in 2008 at the University of Washington, and developed a technical concept into an enabling, commercializable technology. - Website
http://www.impelneuropharma.com - Transaction Type
Venture Equity - Transaction Amount
$12,000,000 - Transaction Round
Series B - Proceeds Purposes
The company intends to use the funds to commercialize its technology. - M&A Terms
- Venture Investor
3M Corporation - Venture Investor
Undisclosed
